Acceptability of COVID-19 Vaccines and Protective Behavior among Adults in Taiwan: Associations between Risk Perception and Willingness to Vaccinate against COVID-19
Abstract
:1. Introduction
2. Materials and Methods
2.1. Research Design
2.2. Measures
2.2.1. Risk Perception, Vaccine Knowledge, and Previous Experience with Vaccination
2.2.2. Willingness to Vaccinate and Personal Health Protective Behaviors Regarding COVID-19
2.3. Statistical Analysis
3. Results
3.1. Individual Characteristics of Participants
3.2. Comparison of Risk Perception and Factors Influencing Vaccination Willingness between Willing and Unwilling to Receive COVID-19 Vaccine Group
3.3. Association between Participants’ Willingness to Receive COVID-19 Vaccine and Their Risk Perception
3.4. Association between Participants’ Health Protective Behaviors and Their Risk Perception
4. Discussion
Limitations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- WHO Statement on the Second Meeting of the International Health Regulations (2005) Emergency Committee Regarding the outbreak of Novel Coronavirus (2019-nCoV). Available online: https://www.who.int/news/item/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) (accessed on 1 March 2021).
- Johns Hopkins University COVID-19 Map-Johns Hopkins Coronavirus Resource Center. Available online: https://coronavirus.jhu.edu/map.html (accessed on 19 February 2021).
- Taiwan Centers for Disease Control Taiwan Timely Identifies First Imported Case of 2019 Novel Coronavirus Infection RETURNING from Wuhan, China through Onboard Quarantine; Central Epidemic Command Center (CECC) Raises Travel Notice Level for Wuhan, China to Level 3: Warning. Available online: https://www.cdc.gov.tw/En/Category/ListContent/tov1jahKUv8RGSbvmzLwFg?uaid=pVg_jRVvtHhp94C6GShRkQ (accessed on 19 February 2021).
- Wang, C.J.; Ng, C.Y.; Brook, R.H. Response to COVID-19 in Taiwan: Big data analytics, new technology, and proactive testing. JAMA J. Am. Med. Assoc. 2020, 323, 1341–1342. [Google Scholar] [CrossRef] [PubMed]
- Taiwan Centers for Disease Control CECC Confirms 1 More Imported COVID-19 Case; Indonesian Man Found to Have COVID-19 before End of Quarantine Period. Available online: https://www.cdc.gov.tw/En/Category/ListContent/tov1jahKUv8RGSbvmzLwFg?uaid=ualy0OtBmXRIvi9zidPbFg (accessed on 19 February 2021).
- Our World in Data Which Countries Have Protected Both Health and the Economy in the pandemic? Available online: https://ourworldindata.org/covid-health-economy (accessed on 19 February 2021).
- Summers, D.J.; Cheng, D.H.-Y.; Lin, P.H.-H.; Barnard, D.L.T.; Kvalsvig, D.A.; Wilson, P.N.; Baker, P.M.G. Potential Lessons from the Taiwan and New Zealand Health Responses to the COVID-19 Pandemic. Lancet Reg. Health West. Pacific 2020. [Google Scholar] [CrossRef]
- Schaffer Deroo, S.; Pudalov, N.J.; Fu, L.Y. Planning for a COVID-19 Vaccination Program. JAMA J. Am. Med. Assoc. 2020, 323, 2458–2459. [Google Scholar] [CrossRef]
- Taiwan Centers for Disease Control CECC is in Talks with Vaccine Suppliers to Purchase nearly 20 million Doses of COVID-19 Vaccines and Expects to Have Vaccines as Early as March 2021. Available online: https://www.cdc.gov.tw/En/Bulletin/Detail/dyGaFbJOfhghSBgOEbH4Lg?typeid=158 (accessed on 19 February 2021).
- World Health Organization Global Advisory Committee on Vaccine Safety, 27–28 May 2020. Available online: https://www.who.int/vaccine_safety/committee/reports/May_2020/en/ (accessed on 19 February 2021).
- Malik, A.A.; McFadden, S.A.M.; Elharake, J.; Omer, S.B. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine 2020, 26, 100495. [Google Scholar] [CrossRef]
- Lazarus, J.V.; Ratzan, S.C.; Palayew, A.; Gostin, L.O.; Larson, H.J.; Rabin, K.; Kimball, S.; El-Mohandes, A. A global survey of potential acceptance of a COVID-19 vaccine. Nat. Med. 2020, 4, 100044. [Google Scholar] [CrossRef] [PubMed]
- Wouters, O.J.; Shadlen, K.C.; Salcher-Konrad, M.; Pollard, A.J.; Larson, H.J.; Teerawattananon, Y.; Jit, M. Challenges in ensuring global access to COVID-19 vaccines: Production, affordability, allocation, and deployment. Lancet 2021. [Google Scholar] [CrossRef]
- Shahin, M.A.H.; Hussien, R.M. Risk perception regarding the COVID-19 outbreak among the general population: A comparative Middle East survey. Middle East Curr. Psychiatry 2020. [Google Scholar] [CrossRef]
- Echoru, I.; Ajambo, P.D.; Bukenya, E.M. Acceptance and risk perception of COVID-19 vaccine in Uganda: A Cross sectional study in Western Uganda. BMC Public Health 2020. [Google Scholar] [CrossRef]
- Janz, N.K.; Becker, M.H. The Health Belief Model: A Decade Later. Health Educ. Behav. 1984. [Google Scholar] [CrossRef] [Green Version]
- Ajzen, I. The theory of planned behavior. Organ. Behav. Hum. Decis. Process. 1991. [Google Scholar] [CrossRef]
- Huang, J.H.; Miao, Y.Y.; Kuo, P.C. Pandemic influenza H1N1 vaccination intention: Psychosocial determinants and implications from a national survey, Taiwan. Eur. J. Public Health 2012. [Google Scholar] [CrossRef]
- Asnakew, Z.; Asrese, K.; Andualem, M. Community risk perception and compliance with preventive measures for covid-19 pandemic in Ethiopia. Risk Manag. Healthc. Policy 2020. [Google Scholar] [CrossRef]
- Kwok, K.O.; Li, K.K.; Chan, H.H.H.; Yi, Y.Y.; Tang, A.; Wei, W.I.; Wong, S.Y.S. Community Responses during Early Phase of COVID-19 Epidemic, Hong Kong. Emerg. Infect. Dis. 2020, 26, 1575–1579. [Google Scholar] [CrossRef] [PubMed]
- Dryhurst, S.; Schneider, C.R.; Kerr, J.; Freeman, A.L.J.; Recchia, G.; van der Bles, A.M.; Spiegelhalter, D.; van der Linden, S. Risk perceptions of COVID-19 around the world. J. Risk Res. 2020. [Google Scholar] [CrossRef]
- Schwarzinger, M.; Watson, V.; Arwidson, P.; Alla, F.; Luchini, S. COVID-19 vaccine hesitancy in a representative working-age population in France: A survey experiment based on vaccine characteristics. Lancet Public Health 2021. [Google Scholar] [CrossRef]
- Nichol, K.L.; Mac Donald, R.; Hauge, M. Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults. J. Gen. Intern. Med. 1996. [Google Scholar] [CrossRef] [PubMed]
- MacDonald, N.E.; Eskola, J.; Liang, X.; Chaudhuri, M.; Dube, E.; Gellin, B.; Goldstein, S.; Larson, H.; Manzo, M.L.; Reingold, A.; et al. Vaccine hesitancy: Definition, scope and determinants. Vaccine 2015. [Google Scholar] [CrossRef] [PubMed]
- Dodd, R.H.; Pickles, K.; Nickel, B.; Cvejic, E.; Ayre, J.; Batcup, C.; Bonner, C.; Copp, T.; Cornell, S.; Dakin, T.; et al. Concerns and motivations about COVID-19 vaccination. Lancet Infect. Dis. 2021, 21, 161. [Google Scholar] [CrossRef]
- Tsai, F.J. Integrated Research Program on Ethics, Law, and Social Impact of Vaccine Development and Application: New and Under-Verified Public Policies and Social Awareness of Vaccine Introduction; Taipei, 2014; Available online: https://www.grb.gov.tw/search/planDetail?id=11273060&docId=455873 (accessed on 16 March 2021).
- World Health Organization COVID-19: Vulnerable and High Risk Groups. Available online: https://www.who.int/westernpacific/emergencies/covid-19/information/high-risk-groups#:~:text=COVID-19 (accessed on 19 February 2021).
- World Health Organization WHO SAGE Roadmap For Prioritizing Uses Of COVID-19 Vaccines In The Context Of Limited Supply. Available online: https://www.who.int/publications/m/item/who-sage-roadmap-for-prioritizing-uses-of-covid-19-vaccines-in-the-context-of-limited-supply (accessed on 19 February 2021).
- Williams, L.; Gallant, A.J.; Rasmussen, S.; Brown Nicholls, L.A.; Cogan, N.; Deakin, K.; Young, D.; Flowers, P. Towards intervention development to increase the uptake of COVID-19 vaccination among those at high risk: Outlining evidence-based and theoretically informed future intervention content. Br. J. Health Psychol. 2020. [Google Scholar] [CrossRef]
- Goldman, R.D.; Marneni, S.R.; Seiler, M.; Brown, J.C.; Klein, E.J.; Cotanda, C.P.; Gelernter, R.; Yan, T.D.; Hoeffe, J.; Davis, A.L.; et al. Caregivers’ willingness to accept expedited vaccine research during the COVID-19 pandemic: A cross-sectional survey. Clin. Ther. 2020. [Google Scholar] [CrossRef]
- Paul, E.; Steptoe, A.; Fancourt, D. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. Lancet Reg. Health Eur. 2021. [Google Scholar] [CrossRef] [PubMed]
- Lucia, V.C.; Kelekar, A.; Afonso, N.M. COVID-19 vaccine hesitancy among medical students. J. Public Health 2020. [Google Scholar] [CrossRef]
- Guidry, J.P.D.; Laestadius, L.I.; Vraga, E.K.; Miller, C.A.; Perrin, P.B.; Burton, C.W.; Ryan, M.; Fuemmeler, B.F.; Carlyle, K.E. Willingness to get the COVID-19 vaccine with and without emergency use authorization. Am. J. Infect. Control 2021. [Google Scholar] [CrossRef] [PubMed]
- Bond, L.; Nolan, T. Making sense of perceptions of risk of diseases and vaccinations: A qualitative study combining models of health beliefs, decision-making and risk perception. BMC Public Health 2011. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sherman, S.M.; Smith, L.E.; Sim, J.; Amlôt, R.; Cutts, M.; Dasch, H.; Rubin, G.J.; Sevdalis, N. COVID-19 vaccination intention in the UK: Results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum. Vaccines Immunother. 2020. [Google Scholar] [CrossRef]
- Ozawa, S.; Stack, M.L. Public trust and vaccine acceptance-international perspectives. Hum. Vaccines Immunother. 2013, 9, 1774–1778. [Google Scholar] [CrossRef]
- Larson, H.J.; Clarke, R.M.; Jarrett, C.; Eckersberger, E.; Levine, Z.; Schulz, W.S.; Paterson, P. Measuring trust in vaccination: A systematic review. Hum. Vaccines Immunother. 2018, 14, 1599–1609. [Google Scholar] [CrossRef]
Variables | Total (n = 1020) | Unwilling (n = 482) | Willing (n = 538) | p-Value | |||
---|---|---|---|---|---|---|---|
n | % | n | % | n | % | ||
Sex (n = 1020) | |||||||
Male | 442 | 43.3% | 192 | 39.8% | 250 | 46.5% | 0.033 |
Female | 578 | 56.7% | 290 | 60.2% | 288 | 53.5% | |
Education (n = 1014) | |||||||
High school and below | 458 | 45.2% | 176 | 36.8% | 282 | 52.6% | <0.001 |
College | 479 | 47.2% | 259 | 54.2% | 220 | 41.0% | |
Master and above | 77 | 7.6% | 43 | 9.0% | 34 | 6.3% | |
Age groups (n = 1020) | |||||||
20~39 | 187 | 17.4% | 83 | 17.2% | 104 | 19.3% | 0.238 |
40~59 | 471 | 43.7% | 236 | 49.0% | 235 | 43.7% | |
Above 60 (including) | 362 | 33.6% | 163 | 33.8% | 199 | 37.0% | |
Religion (n = 1016) | |||||||
Folk religion (including Taoism and Yiguandao) | 291 | 28.6% | 127 | 26.5% | 164 | 30.5% | 0.326 |
Christianity | 53 | 5.2% | 28 | 5.8% | 25 | 4.7% | |
Buddhism | 306 | 30.1% | 141 | 29.4% | 165 | 30.7% | |
No religion | 366 | 36.0% | 183 | 38.2% | 183 | 34.1% | |
Occupational status (n = 1007) | |||||||
Employed | 617 | 61.3% | 307 | 64.6% | 310 | 58.3% | 0.039 |
Unemployed/retired | 390 | 38.7% | 168 | 35.4% | 222 | 41.7% |
Variables | Total (n = 1020) | Unwilling (n = 482) | Willing (n = 538) | p-Value | |||
---|---|---|---|---|---|---|---|
n | % | n | % | b | % | ||
Knowledge (n = 1020) | |||||||
High scores (7–10) | 346 | 33.9% | 155 | 32.2% | 191 | 35.5% | 0.497 |
Medium scores (5–6) | 391 | 38.3% | 192 | 39.8% | 199 | 37.0% | |
Low scores (1–4) | 283 | 27.7% | 135 | 28.0% | 148 | 27.5% | |
Experience of vaccine refusal (n = 1010) | |||||||
Ever | 289 | 28.6% | 187 | 39.3% | 102 | 19.1% | <0.001 |
None | 721 | 71.4% | 289 | 60.7% | 432 | 80.9% | |
Severity of the COVID-19 pandemic in Taiwan (n = 1002) | |||||||
Serious | 142 | 14.2% | 81 | 17.1% | 61 | 11.6% | 0.046 |
Not serious/slightly serious | 224 | 22.4% | 102 | 21.5% | 122 | 23.1% | |
Not serious | 636 | 63.5% | 292 | 61.5% | 344 | 65.3% | |
Worried about contracting COVID-19 (n = 1017) | |||||||
Worried | 638 | 62.7% | 298 | 61.8% | 340 | 63.6% | 0.570 |
Not worried | 379 | 37.3% | 184 | 38.2% | 195 | 36.4% |
Estimated Odds Ratios of Unwillingness to Receive COVID-19 Vaccination | ||||
---|---|---|---|---|
Variables | Crude OR (95% CI) | p-Value | Adjusted OR (95% CI) | p-Value |
Sex | ||||
Male | (ref) | (ref) | ||
Female | 1.311 (1.022–1.682) | 0.033 | 1.344 (1.016–1.779) | 0.039 |
Education | ||||
High school and below | (ref) | (ref) | ||
College | 1.866 (1.454–2.447) | <0.001 | 2.100 (1.550–2.844) | <0.001 |
Master and above | 2.026 (1.244–3.300) | 0.005 | 2.399 (1.396–4.123) | 0.002 |
Age groups | ||||
20~39 | (ref) | (ref) | ||
40~59 | 1.258 (0.895–1.769) | 0.186 | 1.667 (1.145–2.427) | 0.008 |
Above 60 (including) | 1.026 (0.720–1.464) | 0.886 | 1.967 (1.254–3.086) | 0.003 |
Occupational status | ||||
Unemployed/retired | (ref) | (ref) | ||
Employed | 1.309 (1.014–1.689) | 0.039 | 1.442 (1.056–1.970) | 0.021 |
Experience of vaccine refusal | ||||
None | (ref) | (ref) | ||
Ever | 2.740 (2.064–3.639) | <0.001 | 2.435 (1.806–3.282) | <0.001 |
Severity of the COVID-19 pandemic in Taiwan | ||||
Not serious | (ref) | (ref) | ||
Not serious/slightly serious | 0.985 (0.726–1.337) | 0.923 | 1.042 (0.751–1.445) | 0.806 |
Serious | 1.564 (1.084–2.258) | 0.017 | 1.546 (1.031–2.320) | 0.035 |
Worried about contracting COVID-19 | ||||
Not worried | (ref) | (ref) | ||
Worried | 0.929 (0.720–1.198) | 0.570 | 0.795 (0.601–1.053) | 0.110 |
Estimated Odds Ratios of Poor Health Protective Behaviors for COVID-19 Prevention | ||||
---|---|---|---|---|
Variables | Crude OR (95% CI) | p-Value | Adjusted OR (95% CI) | p-Value |
Sex | ||||
Male | (ref) | (ref) | ||
Female | 0.694 (0.540–0.892) | 0.004 | 0.737 (0.564–0.964) | 0.026 |
Education | ||||
High school and below | (ref) | (ref) | ||
College | 0.843 (0.652–1.091) | 0.195 | 0.775 (0.580–1.037) | 0.086 |
Master and above | 1.023 (0.629–1.664) | 0.927 | 0.937 (0.555–1.583) | 0.809 |
Age groups | ||||
20~39 | (ref) | (ref) | ||
40~59 | 0.900 (0.640–1.266) | 0.545 | 0.861 (0.599–1.238) | 0.420 |
Above 60 (including) | 0.872 (0.612–1.244) | 0.451 | 0.810 (0.526–1.246) | 0.337 |
Occupational status | ||||
Unemployed/retired | (ref) | (ref) | ||
Employed | 1.207 (0.935–1.557) | 0.149 | 1.082 (0.806–1.466) | 0.583 |
Severity of the COVID-19 pandemic in Taiwan | ||||
Not serious | (ref) | (ref) | ||
Not serious/slightly serious | 1.116 (0.820–1.519) | 0.485 | 1.195 (0.870–1.641) | 0.272 |
Serious | 0.718 (0.498–1.035) | 0.075 | 0.842 (0.573–1.238) | 0.382 |
Worried about contracting COVID-19 | ||||
Not worried | (ref) | (ref) | ||
Worried | 0.650 (0.502–0.842) | 0.001 | 0.685 (0.522–0.900) | 0.007 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Tsai, F.-J.; Yang, H.-W.; Lin, C.-P.; Liu, J.Z. Acceptability of COVID-19 Vaccines and Protective Behavior among Adults in Taiwan: Associations between Risk Perception and Willingness to Vaccinate against COVID-19. Int. J. Environ. Res. Public Health 2021, 18, 5579. https://doi.org/10.3390/ijerph18115579
Tsai F-J, Yang H-W, Lin C-P, Liu JZ. Acceptability of COVID-19 Vaccines and Protective Behavior among Adults in Taiwan: Associations between Risk Perception and Willingness to Vaccinate against COVID-19. International Journal of Environmental Research and Public Health. 2021; 18(11):5579. https://doi.org/10.3390/ijerph18115579
Chicago/Turabian StyleTsai, Feng-Jen, Hsiu-Wen Yang, Chia-Ping Lin, and Jeffrey Zen Liu. 2021. "Acceptability of COVID-19 Vaccines and Protective Behavior among Adults in Taiwan: Associations between Risk Perception and Willingness to Vaccinate against COVID-19" International Journal of Environmental Research and Public Health 18, no. 11: 5579. https://doi.org/10.3390/ijerph18115579
APA StyleTsai, F. -J., Yang, H. -W., Lin, C. -P., & Liu, J. Z. (2021). Acceptability of COVID-19 Vaccines and Protective Behavior among Adults in Taiwan: Associations between Risk Perception and Willingness to Vaccinate against COVID-19. International Journal of Environmental Research and Public Health, 18(11), 5579. https://doi.org/10.3390/ijerph18115579